tiprankstipranks
Trending News
More News >
Lyell Immunopharma, Inc. (LYEL)
:LYEL
US Market

Lyell Immunopharma (LYEL) Income Statement

Compare
140 Followers

Lyell Immunopharma Income Statement

Last quarter (Q1 2025), Lyell Immunopharma's total revenue was $7.00K, an increase of 133.33% from the same quarter last year. In Q1, Lyell Immunopharma's net income was $-52.20M. See Lyell Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 61.00K$ 130.00K$ 84.68M$ 10.65M$ 7.76M
Gross Profit
$ 61.00K$ 130.00K$ 68.22M$ -3.88M$ 281.00K
Operating Expenses
$ 358.82M$ 247.14M$ 276.50M$ 225.43M$ 219.69M
Depreciation and Amortization
$ 19.63M$ 20.25M$ 16.47M$ 14.54M$ 7.47M
EBITDA
$ -200.64M$ -226.76M$ -166.65M$ -199.94M$ -207.64M
Operating Income
$ -358.75M$ -247.01M$ -183.12M$ -214.78M$ -211.94M
Other Income/Expenses
$ 15.76M$ 12.38M$ 3.84M$ -36.65M$ 7.46M
Pretax Income
$ -342.99M$ -234.63M$ -183.12M$ -250.22M$ -204.47M
Net Income
$ -342.99M$ -234.63M$ -4.75M$ -285.50M$ -198.53M
Per Share Metrics
Basic EPS
$ -1.31$ -0.93$ -0.02$ -1.18$ -0.81
Diluted EPS
$ -1.31$ -0.93$ -0.02$ -1.18$ -0.81
Weighted Average Shares Outstanding
13.07M 12.55M 12.35M 12.14M 12.33M
Weighted Average Shares Outstanding (Diluted)
13.07M 12.55M 12.35M 12.14M 12.33M
Currency in USD

Lyell Immunopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis